These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 1816765

  • 1. Cardiovascular profile of oxodipine, a novel dihydropyridine calcium channel blocker, in anesthetized open-chest dogs: a comparison with nitrendipine.
    Alloui A, Talmant JM, Duchêne-Marullaz P.
    Arch Int Pharmacodyn Ther; 1991; 313():63-75. PubMed ID: 1816765
    [Abstract] [Full Text] [Related]

  • 2. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC, Zyvoloski MG, Gross GJ, Brooks HL.
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [Abstract] [Full Text] [Related]

  • 3. Effect of oxodipine, a novel dihydropyridine calcium channel blocker, in neurogenic hypertensive dogs.
    Montastruc P, Montastruc JL, Dubreuil J, Galiano A.
    Arch Int Pharmacodyn Ther; 1993 Aug; 321():57-62. PubMed ID: 8323416
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs.
    Mori T, Nakayama N, Ohura M, Ikezono K, Kinoshita S, Kamata M, Hosokawa T, Yamashita S, Yabuuchi Y.
    Arch Int Pharmacodyn Ther; 1993 Aug; 321():41-56. PubMed ID: 8323415
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hemodynamic effects of a dihydropyridine calcium antagonist, NB-818 (NPK-1886) in anesthetized dogs.
    Nishikibe M, Nagura J, Kamei K, Fukuroda T.
    Arch Int Pharmacodyn Ther; 1988 Aug; 291():7-20. PubMed ID: 3365068
    [Abstract] [Full Text] [Related]

  • 8. Effects of niguldipine, a new dihydropyridine calcium antagonist, on regional blood flow, cardiac performance and myocardial metabolism in anaesthetized open-chest dogs.
    Fischer G, Schneider W, Krumpl G, Grohs JG, Raberger G.
    Arch Int Pharmacodyn Ther; 1989 Aug; 298():96-107. PubMed ID: 2757470
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
    Germini M, Passoni A, Casciarri I, Bosetti P, Piazzoni L, Cazzulani P, Gandolfi CA, Tofanetti O, Ceserani R.
    Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular effects of YM-16151-1 and its optical isomers: a novel calcium entry blocking and beta 1-adrenoceptor blocking agent.
    Uchida W, Shibasaki K, Asano M, Takenaka T.
    Arch Int Pharmacodyn Ther; 1993 Jan; 321():30-40. PubMed ID: 8100704
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M, Takasuna K, Yamashita N, Tamura K.
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular effects of a new dihydropyridine calcium antagonist.
    Kimura Y, Fukui H, Tanaka M, Okamoto M, Miura A, Kimura K, Enomoto H.
    Arzneimittelforschung; 1986 Sep; 36(9):1336-44. PubMed ID: 3790183
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
    Saitoh C, Momose K, Tanaka H, Sato S, Taguchi K, Saitoh M, Maehara J, Asano M, Usuda S.
    Arzneimittelforschung; 1998 Feb; 48(2):125-32. PubMed ID: 9541721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.